These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25899240)

  • 1. Response to letter regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
    Coutts SB; Hill MD
    Stroke; 2015 Jun; 46(6):e150. PubMed ID: 25899240
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Behrouz et Al regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
    Behrouz R; Mutgi SA; Silver B
    Stroke; 2015 Jun; 46(6):e149. PubMed ID: 25899241
    [No Abstract]   [Full Text] [Related]  

  • 3. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro: intravenous tissue plasminogen activator in stroke patients with rapid, complete recovery during evaluation (transient ischemic attack) and evidence of middle cerebral artery occlusion.
    Köhrmann M; Schellinger PD
    Stroke; 2010 Dec; 41(12):3003-4. PubMed ID: 21030698
    [No Abstract]   [Full Text] [Related]  

  • 5. Tenecteplase versus alteplase for acute ischemic stroke.
    González RG
    N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969
    [No Abstract]   [Full Text] [Related]  

  • 6. Tenecteplase for acute ischemic stroke.
    Lyden P
    Int J Stroke; 2011 Dec; 6(6):509-10. PubMed ID: 22111795
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Liao X; Wang Y; Wang Y
    Stroke; 2014 Dec; 45(12):e304. PubMed ID: 25342031
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete recovery following intra-arterial tenecteplase administration in a woman with acute ischemic stroke.
    Meenakshi-Sundaram S; Periakaruppan A; Karuppiah SN; Karthik SN; Roopakumar L; Thembavani I
    J Clin Neurosci; 2013 Dec; 20(12):1786-8. PubMed ID: 23938013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking up is hard to do: tenecteplase in acute stroke.
    Schwamm LH
    Lancet Neurol; 2015 Apr; 14(4):343-5. PubMed ID: 25726503
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Chao AC; Po HL; Chan L
    Stroke; 2014 Dec; 45(12):e303. PubMed ID: 25342029
    [No Abstract]   [Full Text] [Related]  

  • 11. Tenecteplase: More Evidence It Should Replace Alteplase for Ischemic Stroke Treatment.
    Kreitzer N
    Ann Emerg Med; 2023 Dec; 82(6):729-731. PubMed ID: 37598332
    [No Abstract]   [Full Text] [Related]  

  • 12. Tenecteplase for acute ischaemic stroke.
    Sandset EC; Tsivgoulis G
    Lancet; 2022 Jul; 400(10347):138-139. PubMed ID: 35779556
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel lytics, novel imaging: a new treatment strategy in stroke?
    Quinn TJ; Dawson J
    J Comp Eff Res; 2012 Jul; 1(4):311-4. PubMed ID: 24237464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenecteplase for stroke salvage therapy--extending the therapeutic window via CT based selection.
    Kamran S; Muzammil SM; Kamal AK
    J Pak Med Assoc; 2013 Mar; 63(3):406-7. PubMed ID: 23914652
    [No Abstract]   [Full Text] [Related]  

  • 15. Freezing Tenecteplase Into Aliquots to Reduce Waste in Acute Ischemic Stroke.
    Kaur H; Merkel A; Hackett CT; Finoli L; Seidl E; Reardon C; Cerejo R
    Stroke; 2024 Jan; 55(1):e1-e2. PubMed ID: 38063015
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-assisted thrombolysis for delayed arrival among patients with ischemic stroke.
    Khatri R; Miley JT; Qureshi AI
    J Neuroimaging; 2011 Oct; 21(4):307-8. PubMed ID: 21121999
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Bruno A; Switzer JA
    Neurology; 2012 Jul; 79(5):486-7; author reply 486-7. PubMed ID: 22851721
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Kent TA
    Neurology; 2012 Apr; 78(17):1368. PubMed ID: 22529207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.